II. Epidemiology
- Typically affects age <5 years old (and especially <2 years)
- Incidence: <0.56 per Million (rare)
III. Pathophysiology
- Group 2 Coagulase Positive Staphylococcus aureus strains
- Strains that carry exfoliative toxins A and B (only 5% of S. aureus strains)
- Breaks down desmoglein-1 resulting in epidermolysis or Acantholysis (breakage of cell to cell adhesions)
- Similar to Pemphigus Vulgaris (which in contrast is immune mediated)
- Sources
- Initial localized infection
- Skin sites (e.g. Diaper Dermatitis, ubilicus, face)
- Nn-skin sites (e.g. Otitis Media, Upper Respiratory Infection
- Later, hematologic dissemination of Staphylococcus aureus from an infectious source
- Contrast with Impetigo which spreads contiguously
- Initial localized infection
IV. Symptoms
- Prodrome (initial Upper Respiratory Infection)
- Acute phase (initial, prior to Desquamation)
- Fever
- Malaise
- Irritability
- Red, painful skin
V. Signs
- Red, scarlatiniform, sandpaper-like rash
- Paper-thin skin that desquamates (Exfoliative Dermatitis)
- Distribution especially in the flexor creases, perioral area, neck and groin
- Large, flaccid Blisters
- Positive Nikolsky Sign (on affected skin)
- No mucous membrane involvement
VI. Labs
-
Blood Cultures
- Bacteremia is often present in Staphylococcal Scalded Skin Syndrome
- Skin biopsy
- Exotoxin assay
- Avoid skin lesion cultures
- Lesions are sterile and will be non-diagnostic
VII. Differential Diagnosis
VIII. Management
- Admit patients with diffuse involvement to ICU or burn unit
- Intravenous Antibiotics covering Staphylococcus aureus (consider MRSA coverage depending on risk)
- Methicillin Sensitive Staphylococcus aureus infections account for 95% of cases (as of 2018)
- Systemic Corticosteroids may be used in non-toxic appearing patients
- Adjunctive measures in severe cases
- Intravenous Immunoglobulin
- Plasmapheresis
IX. Course
- Resolution in 5-7 days after Antibiotics are initiated
X. References
- Long (2016) Crit Dec Emerg Med 30(7):3-10
- Stewart (2022) Crit Dec Emerg Med 36(1): 16-7
- Rare Disease Database, accessed 1/13/2022